Financials
- Market Capitalization 5.0334 B
- Employee 362
- Founded 2018
- CEO N/A
- Website www.immunovant.com
- Headquarter Delaware, United States
- FIGI BBG00P5MC0Q8
- Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
5.03 B Market capitalization
Price to earnings ratio
-9.49
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—